Commodore Capital Lp

Insider Reports History

Entity
Company
Location
444 Madison Avenue, 35 Th Floor, New York, New York
Signature
/s/ Michael Kramarz, Managing Partner
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Commodore Capital Lp:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Ambrx Biopharma Inc. 10%+ Owner Ordinary Shares 35.7M $330M $9.24 Feb 23, 2023 By Commodore Capital Master LP
Vera Therapeutics, Inc. 10%+ Owner Class A Common Stock 4.4M $79.2M $18.00 Jan 10, 2024 By Commodore Capital Master LP
Enliven Therapeutics, Inc. 10%+ Owner Common stock, par value $0.001 per share 1.45M $21.9M $15.14 Feb 23, 2023 By Commodore Capital Master LP
Satsuma Pharmaceuticals, Inc. 10%+ Owner Common Stock, par value $0.0001 per share 461K $326K $0.71 Nov 14, 2022 By Commodore Capital Master LP
Vistagen Therapeutics, Inc. 10%+ Owner Pre-Funded Warrants (Right to Buy) 2.79M Oct 4, 2023 By Commodore Capital Master LP
Vistagen Therapeutics, Inc. 10%+ Owner Tranche 2 Warrants (Right to Buy) 1.69M Oct 4, 2023 By Commodore Capital Master LP
Vistagen Therapeutics, Inc. 10%+ Owner Tranche 1 Warrants (Right to Buy) 1.39M Oct 4, 2023 By Commodore Capital Master LP

Insider Reports Filed by Commodore Capital Lp

Symbol Company Period Transactions Value $ Form Type Date Filed Role
VERA Vera Therapeutics, Inc. Jan 10, 2024 1 -$18.9M 4 Jan 12, 2024 10%+ Owner
VTGN Vistagen Therapeutics, Inc. Oct 4, 2023 3 $0 4 Oct 6, 2023 10%+ Owner
VTGN Vistagen Therapeutics, Inc. Aug 7, 2023 1 $18M 4 Aug 9, 2023 10%+ Owner
VTGN Vistagen Therapeutics, Inc. Aug 7, 2023 0 $0 3 Aug 9, 2023 10%+ Owner
VERA Vera Therapeutics, Inc. Jun 20, 2023 1 $6.8M 4 Jun 22, 2023 10%+ Owner
VERA Vera Therapeutics, Inc. Jun 14, 2023 0 $0 3 Jun 22, 2023 10%+ Owner
AMAM Ambrx Biopharma Inc. Feb 23, 2023 0 $0 3 Mar 3, 2023 10%+ Owner
ELVN Enliven Therapeutics, Inc. Feb 23, 2023 2 $13.7K 4 Feb 27, 2023 10%+ Owner
ELVN IMARA Inc. Feb 21, 2023 2 $163K 4 Feb 23, 2023 10%+ Owner
ELVN IMARA Inc. Feb 15, 2023 0 $0 3 Feb 21, 2023 10%+ Owner
STSA Satsuma Pharmaceuticals, Inc. Nov 14, 2022 1 -$2.29M 4 Nov 16, 2022 10%+ Owner
STSA Satsuma Pharmaceuticals, Inc. Nov 24, 2021 1 $15.8K 4 Nov 29, 2021 10%+ Owner
STSA Satsuma Pharmaceuticals, Inc. Nov 19, 2021 2 $72.3K 4 Nov 23, 2021 10%+ Owner
STSA Satsuma Pharmaceuticals, Inc. Nov 10, 2021 2 $104K 4 Nov 12, 2021 10%+ Owner
STSA Satsuma Pharmaceuticals, Inc. Nov 8, 2021 1 $3.35K 4 Nov 10, 2021 10%+ Owner
STSA Satsuma Pharmaceuticals, Inc. Nov 4, 2021 2 $54.6K 4 Nov 8, 2021 10%+ Owner
STSA Satsuma Pharmaceuticals, Inc. Nov 2, 2021 1 $50.1K 4 Nov 4, 2021 10%+ Owner
STSA Satsuma Pharmaceuticals, Inc. Oct 29, 2021 1 $255K 4 Nov 2, 2021 10%+ Owner
STSA Satsuma Pharmaceuticals, Inc. Oct 27, 2021 2 $299K 4 Oct 29, 2021 10%+ Owner
STSA Satsuma Pharmaceuticals, Inc. Oct 21, 2021 2 $329K 4 Oct 25, 2021 10%+ Owner
STSA Satsuma Pharmaceuticals, Inc. Oct 19, 2021 2 $665K 4 Oct 21, 2021 10%+ Owner
STSA Satsuma Pharmaceuticals, Inc. Oct 15, 2021 2 $785K 4 Oct 19, 2021 10%+ Owner
STSA Satsuma Pharmaceuticals, Inc. Oct 14, 2021 0 $0 3 Oct 19, 2021 10%+ Owner